Qube Research & Technologies (QRT)
VTVT icon

Qube Research & Technologies (QRT)’s vTv Therapeutics VTVT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Buy
+5,618
New +$204K ﹤0.01% 2929
2024
Q3 		– Sell
-1
Closed -$18 – 4182
2024
Q2 		$18 Buy
+1
New +$24 ﹤0.01% 3586

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Qube Research & Technologies (QRT)'s VTVT Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in vTv Therapeutics (VTVT) in Q1 2026: 5,618 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #2929 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in VTVT as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in VTVT in Q2 2024 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Qube Research & Technologies (QRT) held 5,618 shares of vTv Therapeutics worth $223K as of Q1 2026.
  • vTv Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • vTv Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2929 holding.
  • Qube Research & Technologies (QRT) first reported a position in vTv Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.